Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Dec;21(6):461-7.
doi: 10.1097/MED.0000000000000103.

T-cells and B-cells in osteoporosis

M Neale Weitzmann  1
Affiliations
Review

T-cells and B-cells in osteoporosis

M Neale Weitzmann. Curr Opin Endocrinol Diabetes Obes. 2014 Dec.

Abstract

Purpose of review: Bone disease is a leading cause of fractures and continues to be a source of significant morbidity and mortality worldwide. As the underlying mechanisms of osteoporosis are elucidated, immune dysfunction continues to emerge as a key precipitating factor in multiple bone disease contexts. This review examines recent findings in the osteoimmunology field and their implications for bone disease and for novel future therapeutic approaches to rejuvenate the skeleton.

Recent findings: T-cells and B-cells have long been recognized to play important roles in the etiology of inflammatory bone disease; however, new findings continue to challenge our understanding of the depth of the immuno-skeletal interface. In this review, we examine recent evidence for new roles of B-cells in oestrogen deficiency bone loss; central actions of interleukin-7 in the cause of T-cell mediated tissue destruction in rheumatoid arthritis; novel RANKL-independent alveolar bone loss in periodontal infection; and a putative role for γδ T-cells in bisphosphonate-associated osteonecrosis of the jaw. Finally, evidence for novel bone anabolic activities mediated through T-cells by the CD28 antagonist CTLA-4Ig and by intermittently administered parathyroid hormone are examined.

Summary: As the field of osteoimmunology continues to mature, new interrelationships between immune cells and bone turnover continue to emerge.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest

There are no conflicts of interest.

Figures

FIGURE 1
FIGURE 1
Effect of the immune system on bone catabolism.
FIGURE 2
FIGURE 2
Effect of the immune system on bone anabolism.
See this image and copyright information in PMC

References

    1. Weitzmann MN, Pacifici R. Estrogen deficiency and bone loss: an inflammatory tale. J Clin Invest. 2006;116:1186–1194. - PMC - PubMed
    1. Vikulina T, Fan X, Yamaguchi M, et al. Alterations in the immuno-skeletal interface drive bone destruction in HIV-1 transgenic rats. Proc Natl Acad Sci U S A. 2010;107:13848–13853. - PMC - PubMed
    1. Onal M, Xiong J, Chen X, et al. Receptor activator of nuclear factor kappaB ligand (RANKL) protein expression by B lymphocytes contributes to ovariectomy-induced bone loss. J Biol Chem. 2012;287:29851–29860. - PMC - PubMed
    1. Tawfeek H, Bedi B, Li JY, et al. Disruption of PTH receptor 1 in T cells protects against PTH-induced bone loss. PLoS One. 2010;5:e12290. - PMC - PubMed

    1. Jarry CR, Duarte PM, Freitas FF, et al. Secreted osteoclastogenic factor of activated T cells (SOFAT), a novel osteoclast activator, in chronic periodontitis. Hum Immunol. 2013;74:861–866. This study implicates for the first time a role for SOFAT in human bone loss in periodontal infection and provides the first demonstration of SOFAT activity in mice in vivo.

Publication types

MeSH terms

Substances